Win statistics applied to registry-based randomized clinical trials
Win statistics offer an alternative approach to traditional survival analysis by harnessing multiple events hierarchically by clinical importance. Win statistics also offer the potential to evaluate a broader range of clinical endpoints, providing a more rounded perspective of treatment efficacy, an important consideration when designing future randomized controlled trials. This is the first multi-registry-based controlled trial reanalysis using win statistics.
Authors
- Robin Hofmann (ORCID: https://orcid.org/0000-0002-8907-895X)
- Rebecca Tremain Rylance (ORCID: https://orcid.org/0000-0002-5921-3786)
- Stefan James
- Moman A. Mohammad (ORCID: https://orcid.org/0000-0003-4242-9801)
- Philippe Wagner (ORCID: https://orcid.org/0000-0002-9293-3371)
- Ole Fröbert
- Matthias Götberg
- David Erlinge
Institutions
- Uppsala University (SE)
- Lund University (SE)
- Aarhus University (DK)
- Örebro University (SE)
- Karolinska Institutet (SE)
- Stockholm South General Hospital (SE)
- Skåne University Hospital (SE)
Publication Details
- Journal
- Trials
- Published
- 2026-03-07
- DOI
- https://doi.org/10.1186/s13063-026-09598-3
- Primary Topic
- Statistical Methods in Clinical Trials
- Type
- article
- Field-Weighted Citation Impact
- 0.00